Research location
Lillehammer
Oppland, Norway
Advertisement
Research activity in Lillehammer
Oppland, NorwayCureCurrent currently publishes aggregate city-level research activity for this location: 6 trials and 6 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lillehammer
6 linked trials · page 1 of 1The Norwegian Antirheumatic Drug RegisterNCT01581294 · 2012-04-01 · 1 site observation
RECRUITING
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)NCT04121403 · 2019-10-16 · 1 site observation
COMPLETED
Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary DiseaseNCT01318174 · 2011-04-01 · 1 site observation
COMPLETED
Collaboration Between Department of Old Age Psychiatry and Nursing HomesNCT01217541 · 2010-09-01 · 1 site observation
COMPLETED
Chronotherapy in Acute Multiple Sclerosis (MS) AttackNCT00764413 · 2009-04-01 · 1 site observation
TERMINATED
Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic TreatmentNCT00902005 · 2008-04-01 · 1 site observation
COMPLETED
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.